One Capital Management’s VanEck Biotech ETF BBH Stock Holding History

One Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-129	Closed	-$14K	–	171
2014 Q3	$14K	Buy	+129	New	+$13.1K	0.01%	391

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

One Capital Management's BBH Position: Q4 2014 in Review

One Capital Management sold out of VanEck Biotech ETF (BBH) in Q4 2014, closing a stake of 129 shares — an estimated $14K sold.

One Capital Management first reported a position in BBH in Q3 2014 and held it in 1 quarter. The position peaked at $14K in Q3 2014. 68 funds tracked by Wall St. Rank hold BBH as of Q4 2014.

One Capital Management reported no remaining VanEck Biotech ETF position as of Q4 2014 after selling out during the quarter.
One Capital Management sold 129 VanEck Biotech ETF shares in Q4 2014, an estimated $14K.
One Capital Management first reported a position in VanEck Biotech ETF in Q3 2014 and held it in 1 quarter.
One Capital Management's VanEck Biotech ETF position peaked at $14K in Q3 2014.
68 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2014.

Based on One Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.